New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ANI Pharmaceuticals, Inc.
ANIP
Shape
US Flag

NASDAQ

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

59.51USD
Shape1.19 ( 2.04%)
Market Open
favorite-chart

Relative Strenght

83
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated October 28, 2024
1W -0.95 % 1M -0.25 % 3M -6.33 % 1Y -1.64 %

Key Metrics

Shape
  • Market Cap

    1.25B


  • Shares Outstanding

    21.03M


  • Share in Float

    17.41M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    59.51


  • Average Volume

    355528


  • Beta

    0.71


  • Range

    48.2-70.81


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.anipharmaceuticals.com


  • Sector

    Healthcare


Fundamentals

Shape

13.22x

P/E Ratio

2.28x

P/S Ratio

2.47x

P/B Ratio

0.7

Debt/Equity

5.0%

Net Margin

$1.2

EPS

How ANIP compares to sector?

P/E Ratio

Relative Strength

Shape

ANIP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$706M

Shape412%

2025-Revenue

$2.21

Shape1942%

2025-EPS

$117M

Shape476%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Not converted

2024-10-11

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-37%

0.64
vs 1.01

Q4.22

arrow
arrow

+145%

0.76
vs -1.70

Q1.23

arrow
arrow

+1075%

1.17
vs -0.12

Q2.23

arrow
arrow

+885%

1.28
vs 0.13

Q3.23

arrow
arrow

+98%

1.27
vs 0.64

Q4.23

arrow
arrow

+32%

1
vs 0.76

Q1.24

arrow
arrow

+3%

1.21
vs 1.17

Q2.24

arrow
arrow

-20%

1.02
vs 1.28

Q3.24

arrow
arrow

-15%

1.08
vs 1.27

Q4.24

arrow
arrow

+40%

1.4
vs 1

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+61%

83.8M  vs 52.1M

Q4.22

arrow
arrow

+55%

94.2M  vs 60.9M

Q1.23

arrow
arrow

+66%

106.8M  vs 64.5M

Q2.23

arrow
arrow

+58%

116.5M  vs 73.9M

Q3.23

arrow
arrow

+57%

131.8M  vs 83.8M

Q4.23

arrow
arrow

+40%

131.7M  vs 94.2M

Q1.24

arrow
arrow

+29%

137.4M  vs 106.8M

Q2.24

arrow
arrow

+18%

138M  vs 116.5M

Q3.24

arrow
arrow

+9%

144M  vs 131.8M

Q4.24

arrow
arrow

+29%

170.4M  vs 131.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.04

Q4.22

arrow
arrow

-1%

-0.01
vs -0.03

Q1.23

arrow
arrow

+0%

0
vs -0.01

Q2.23

arrow
arrow

+1%

0.01
vs 0

Q3.23

arrow
arrow

+2%

0.02
vs 0.01

Q4.23

arrow
arrow

+0%

0
vs 0.02

Q1.24

arrow
arrow

+4%

0.04
vs 0

Q2.24

arrow
arrow

-1%

-0.01
vs 0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

120

120
vs 114

5%

Q4.22

arrow
arrow

127

127
vs 120

6%

Q1.23

arrow
arrow

140

140
vs 127

10%

Q2.23

arrow
arrow

173

173
vs 140

24%

Q3.23

arrow
arrow

188

188
vs 173

9%

Q4.23

arrow
arrow

183

183
vs 188

-3%

Q1.24

arrow
arrow

206

206
vs 183

13%

Q2.24

arrow
arrow

203

203
vs 206

-1%

Earnings Growth

Latest News